These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 15275965
1. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases. Michalopoulou M, Nikolaou C, Tavernarakis A, Alexandri NM, Rentzos M, Chatzipanagiotou S, Cambouri C, Vassilopoulos D. Immunol Lett; 2004 Jul 15; 94(3):183-9. PubMed ID: 15275965 [Abstract] [Full Text] [Related]
2. Analysis of soluble interleukin 6 receptor in cerebrospinal fluid in inflammatory and non-inflammatory conditions. Azuma H, Moriyama T, Ikeda H, Oshima M, Okuno A, Sekiguchi S. Cytokine; 2000 Feb 15; 12(2):160-4. PubMed ID: 10671302 [Abstract] [Full Text] [Related]
3. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients. Stelmasiak Z, Kozioł-Montewka M, Dobosz B, Rejdak K. Med Sci Monit; 2001 Feb 15; 7(5):914-8. PubMed ID: 11535934 [Abstract] [Full Text] [Related]
4. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. Rentzos M, Cambouri C, Rombos A, Nikolaou C, Anagnostouli M, Tsoutsou A, Dimitrakopoulos A, Triantafyllou N, Vassilopoulos D. J Neurol Sci; 2006 Feb 15; 241(1-2):25-9. PubMed ID: 16316662 [Abstract] [Full Text] [Related]
5. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica. Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X. Neuroimmunomodulation; 2012 Feb 15; 19(5):304-8. PubMed ID: 22777162 [Abstract] [Full Text] [Related]
6. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis. Carrieri PB, Soscia E, Iacovitti B, Pellicano M, D'Antonio A, Provitera V, Perrella O. Eur Cytokine Netw; 1992 Feb 15; 3(5):495-8. PubMed ID: 1477299 [Abstract] [Full Text] [Related]
7. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC. J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125 [Abstract] [Full Text] [Related]
8. Polymorphisms of the gene encoding the inflammatory cytokine interleukin-6 determine the magnitude of the increase in soluble interleukin-6 receptor levels in Alzheimer's disease. Results of a pilot study. Bagli M, Papassotiropoulos A, Hampel H, Becker K, Jessen F, Bürger K, Ptok U, Rao ML, Möller HJ, Maier W, Heun R. Eur Arch Psychiatry Clin Neurosci; 2003 Feb 01; 253(1):44-8. PubMed ID: 12664314 [Abstract] [Full Text] [Related]
9. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies. Usón J, Balsa A, Pascual-Salcedo D, Cabezas JA, Gonzalez-Tarrio JM, Martín-Mola E, Fontan G. J Rheumatol; 1997 Nov 01; 24(11):2069-75. PubMed ID: 9375862 [Abstract] [Full Text] [Related]
10. Concentrations and origins of soluble interleukin 6 receptor-alpha in serum and synovial fluid. Desgeorges A, Gabay C, Silacci P, Novick D, Roux-Lombard P, Grau G, Dayer JM, Vischer T, Guerne PA. J Rheumatol; 1997 Aug 01; 24(8):1510-6. PubMed ID: 9263143 [Abstract] [Full Text] [Related]
11. Interleukin-6 receptor signaling. II. Bio-availability of interleukin-6 in serum. Gaillard J, Pugnière M, Tresca J, Mani J, Klein B, Brochier J. Eur Cytokine Netw; 1999 Sep 01; 10(3):337-44. PubMed ID: 10477390 [Abstract] [Full Text] [Related]
12. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor. Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE. Rheumatology (Oxford); 2006 Dec 01; 45(12):1485-9. PubMed ID: 16690760 [Abstract] [Full Text] [Related]
13. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. Rose-John S, Scheller J, Elson G, Jones SA. J Leukoc Biol; 2006 Aug 01; 80(2):227-36. PubMed ID: 16707558 [Abstract] [Full Text] [Related]
14. Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. Bartosik-Psujek H, Archelos JJ. J Neurol; 2004 Apr 01; 251(4):414-20. PubMed ID: 15083285 [Abstract] [Full Text] [Related]
15. [Determination of serum soluble interleukin-6 receptor and soluble gp130 levels in patient with pregnancy induced hypertension and its significance]. Li Y, Wang Y, Qi L. Zhonghua Fu Chan Ke Za Zhi; 2001 Jan 01; 36(1):18-9. PubMed ID: 11778537 [Abstract] [Full Text] [Related]
16. Relationship between circulating interleukin-10 (IL-10) with interleukin-6 (IL-6) type cytokines (IL-6, interleukin-11 (IL-11), oncostatin M (OSM)) and soluble interleukin-6 (IL-6) receptor (sIL-6R) in patients with multiple myeloma. Urbańska-Ryś H, Wiersbowska A, Stepień H, Robak T. Eur Cytokine Netw; 2000 Sep 01; 11(3):443-51. PubMed ID: 11022130 [Abstract] [Full Text] [Related]
17. Circulating IL-6-type cytokines and sIL-6R in patients with multiple myeloma. Wierzbowska A, Urbańska-Ryś H, Robak T. Br J Haematol; 1999 May 01; 105(2):412-9. PubMed ID: 10233412 [Abstract] [Full Text] [Related]
18. Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils. Jablonska E, Marcinczyk M. Mediators Inflamm; 2003 Jun 01; 12(3):179-83. PubMed ID: 12857602 [Abstract] [Full Text] [Related]
19. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders. Kittur SD, Kittur DS, Soncrant TT, Rapoport SI, Tourtellotte WW, Nagel JE, Adler WH. Ann Neurol; 1990 Aug 01; 28(2):168-73. PubMed ID: 2221845 [Abstract] [Full Text] [Related]